tiprankstipranks
Trending News
More News >

Maky Zanganeh Insider Profile

60 Followers
Maky Zanganeh, COO at Pharmacyclics, holds 591.83M shares in Summit Therapeutics (Ticker: SMMT), holds 873.47K shares in Pulse Biosciences (Ticker: PLSE), holds 0.00 shares in Pharmacyclics (Ticker: PCYC). Most recently, Maky Zanganeh Bought ― shares of Summit Therapeutics on Sep 11, 2025 for an estimated value of $5.98M.
tipranks
Maky Zanganeh

Maky Zanganeh
Pharmacyclics (PCYC)
COO

Ranked #165 out of 103,606 Corporate Insiders

Profitable Transactions

59%
13 out of 22 Profitable Transactions

Average Return

+91.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$11B
99.86%
0.14%
A breakdown of Maky Zanganeh's holdings

Insider Roles

Summit Therapeutics
(SMMT)
Co- CEO, Director, Ten Percent Owner
Pulse Biosciences
(PLSE)
Director
Roles that Maky Zanganeh holds in companies

Most Profitable Insider Trade

Stock:
Summit Therapeutics
(SMMT)
Rating:Informative Buy
Date:Dec 13, 2023 - Dec 13, 2024
Return:+661.90%
The most profitable trade made by Maky Zanganeh

Maky Zanganeh's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
PCYC
Pharmacyclics
May 27, 2015
Uninformative Sell
3.92M
Pulse Biosciences
Feb 11, 2025
Director
Informative Buy
662.66K
$15.38M
Summit Therapeutics
Sep 11, 2025
Co- CEO, Director, Ten Percent Owner
Informative Buy
5.98M
$11.18B
List of latest transactions for each holding click on a transaction to see Maky Zanganeh's performance on stock

Maky Zanganeh insider profile FAQ

What is the percentage of profitable transactions made by Maky Zanganeh?
The percentage of profitable transactions made by Maky Zanganeh is 59%.
    What is the average return per transaction made by Maky Zanganeh?
    The average return per transaction made by Maky Zanganeh is 91.10%.
      What stocks does Maky Zanganeh hold?
      Maky Zanganeh holds: PCYC, PLSE, SMMT stocks.
        What was Maky Zanganeh’s latest transaction?
        Maky Zanganeh latest transaction was an Informative Buy of $5.98M.
          What was Maky Zanganeh's most profitable transaction?
          Maky Zanganeh’s most profitable transaction was an Informative Buy of SMMT stock on December 13, 2023. The return on the trade was 661.90%.
            What is Maky Zanganeh's role in Pharmacyclics?
            Maky Zanganeh's role in Pharmacyclics is COO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.